Chronic obstructive pulmonary disease, anxiety, and depression: State of the science
| Autor: | Susan McCrone, Heidi Putman-Casdorph |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Population MEDLINE Pulmonary disease Anxiety Critical Care and Intensive Care Medicine Pulmonary Disease Chronic Obstructive Quality of life Internal medicine Prevalence medicine Humans Psychiatry education Depression (differential diagnoses) COPD education.field_of_study Depression business.industry Mortality rate medicine.disease United States respiratory tract diseases Survival Rate medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | Heart & Lung. 38:34-47 |
| ISSN: | 0147-9563 |
| DOI: | 10.1016/j.hrtlng.2008.02.005 |
| Popis: | Background Chronic obstructive pulmonary disease (COPD) affects millions worldwide. Despite advances in the treatments of other chronic diseases, little progress in decreasing COPD morbidity and mortality has been made. The death rate associated with COPD has doubled in 30 years. The presence of psychiatric comorbidities, such as anxiety and depression, has been linked to increased mortality, decreased functional status, and decreased quality of life. Objective This review was undertaken to determine the state of the science of COPD, anxiety, and depression, and to identify nursing implications derived from these findings. Conclusion Although the prevalence of anxiety and depression among patients with COPD is significantly higher than the general population, there are serious barriers to the recognition and treatment of these comorbid conditions. Routine assessment and screening for anxiety and depression in all patients diagnosed with COPD should be considered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect